Watermark
  Back to Search Results

BGB-A317-304

Completed

A Study Evaluating the Efficacy and Safety of Tislelizumab Versus Chemotherapy in Advanced Non-Squamous Non-small Cell Lung Cancer

BeOne Study ID info

BGB-A317-304

ClinicalTrials.gov ID info

NCT03663205

China Drug Trials ID info

CTR20180032

Study Overview

Sex: All

Age: 18 Years / 75 Years

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All

Age: 18 Years / 75 Years

Study Documents

Study Protocol Statistical Analysis Plan